Introduction Duloxetine has previously been reported to be promising in the setting of chemotherapy-induced peripheral neuropathy (CIPN). The aim of this study was to conduct a comprehensive ...

Oncologists vary widely in treating DLBCL with cardiomyopathy, often diverging from guidelines due to limited evidence on ...

Multidrug resistance (MDR) is a major cause of failure of cancer chemotherapy. Fifty-eight ecdysteroids ... synergism or antagonism was observed by combining ecdysteroids with doxorubicin, and ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient DNA mismatch repair (dMMR) colon cancer significantly improved ...

Department of Biomedical Imaging and Radiological Sciences, National Yang Ming University, 155 Sec-2, Li-Nong Street, Taipei 112, Taiwan Article Views are the COUNTER-compliant sum of full text ...

MATHEMATICAL MODEL Biologist Regina Joyce Ferrer from the University of the Philippines analyzes breast cancer organoids. —MICHAEL VELARDE MANILA, Philippines — Biologists from the University ...

In exploratory analyses, the 5-year overall survival in the nivolumab-plus-chemotherapy group was 95.3% (95% CI, 82.7 to 98.8) among the patients with a pathological complete response and 55.7% ...

Whether tarlatamab is more effective than chemotherapy in the treatment of patients whose small-cell lung cancer has progressed during or after initial platinum-based chemotherapy is not known.

Participation in a structured exercise program following surgery and adjuvant chemo improved key survival end points in stage 3 and high-risk stage 2 CRC. The implementation of a 3-year structured ...

Myriam Chalabi reviews data from ATOMIC. CHICAGO – Giving Genentech's immunotherapy Tecentriq (atezolizumab) with chemotherapy after surgery allowed more patients with mismatch repair deficient (dMMR) ...

A promising new therapy can help patients with aggressive advanced breast cancer live longer and delay the need for further chemotherapy, new research has shown. The international study, funded by ...